News
INTERVIEW – Option Finance
30/09/2014 - Articles and publications
Jean-Nicolas Soret and the CFO of Onxeo were interviewed in relation to the cross-border merger of French listed company BioAlliance Pharma and Danish listed company Topotarget, resulting in the formation of Onxeo.